GlassScriptPhysician profile
Hope Torregosa
NPI 1992980130
$727.52
in general payments reported to CMS, 2019-2025
16 companies · $73.50 in 2025
The $73.50 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.77 · 2020: $48.54 · 2021: $35.75 · 2022: $127 · 2023: $248 · 2024: $150 · 2025: $73.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $188.57 | 2021-2023 | Freestyle Libre 3 |
| Insulet Corporation | $115.01 | 2019-2024 | Omnipod |
| Lilly USA, LLC | $80.18 | 2022-2024 | Mounjaro |
| Dexcom, INC. | $60.16 | 2020-2024 | Dexcom G6 Transmitter |
| Beta Bionics, INC. | $38.41 | 2023-2024 | Ilet Bionic Pancreas |
| Medtronic, INC. | $38.26 | 2025 | Minimed 780g |
| Tandem Diabetes Care, INC. | $35.57 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $33.58 | 2023 | |
| Ascensia Diabetes Care US INC. | $24.83 | 2024 | |
| Radius Health, INC. | $22.60 | 2022 | |
| Mannkind Corporation | $19.94 | 2021 | |
| Xeris Pharmaceuticals, INC. | $17.12 | 2020 | |
| Sequel Med Tech, LLC | $16.61 | 2025 | Twiist |
| Companion Medical, INC. | $13.75 | 2019 | |
| Novo Nordisk INC | $13.20 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $9.73 | 2023 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Torregosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.